CSF2 and neoplasm: Other approaches are: blockade of chemoattractants (e.g. anti-CSF [27, 37, 38], anti-VEGF, anti-CXCL12 [27]), signalling pathways (e.g. NF-κB) and cytokines secretion [31]; and depletion of TAMs from the tumor milieu [39].